Kensuke Egashira
#143,578
Most Influential Person Now
Kensuke Egashira's AcademicInfluence.com Rankings
Kensuke Egashirabiology Degrees
Biology
#10291
World Rank
#13605
Historical Rank
Molecular Biology
#1485
World Rank
#1512
Historical Rank
Neuroscience
#1583
World Rank
#1634
Historical Rank
Biochemistry
#1620
World Rank
#1753
Historical Rank
Download Badge
Biology
Kensuke Egashira's Degrees
- PhD Biochemistry University of Tokyo
- Masters Molecular Biology University of Tokyo
- Bachelors Biology University of Tokyo
Similar Degrees You Can Earn
Why Is Kensuke Egashira Influential?
(Suggest an Edit or Addition)Kensuke Egashira's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. (2006) (2410)
- The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. (1996) (701)
- Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. (1994) (648)
- Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. (1993) (600)
- Transforming Growth Factor-&bgr; Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats (2002) (558)
- Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. (1999) (539)
- Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. (2000) (430)
- Endogenous Drp1 Mediates Mitochondrial Autophagy and Protects the Heart Against Energy Stress (2015) (410)
- Effects of Age on Endothelium‐Dependent Vasodilation of Resistance Coronary Artery by Acetycholine in Humans (1993) (386)
- Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells (2003) (377)
- Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. (1993) (372)
- Gene Transfer of Stromal Cell–Derived Factor-1&agr; Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase–Related Pathway: Next-Generation Chemokine Therapy for Therapeutic Neovascularization (2004) (325)
- Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. (1999) (315)
- Angina pectoris caused by coronary microvascular spasm (1998) (309)
- Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. (1996) (298)
- Importance of endothelium-derived hyperpolarizing factor in human arteries. (1997) (283)
- Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation? (2004) (275)
- Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. (1997) (262)
- Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice (2002) (260)
- New Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E-Knockout Mice (2001) (256)
- The critical role of ocular‐infiltrating macrophages in the development of choroidal neovascularization (2003) (255)
- Pioglitazone, a Peroxisome Proliferator-Activated Receptor-&ggr; Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction (2002) (250)
- Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. (1995) (244)
- Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas (2003) (237)
- Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. (2000) (234)
- Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction (2002) (231)
- Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. (1998) (219)
- Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling (2004) (212)
- Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart Failure (2016) (200)
- Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. (1998) (200)
- Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. (1995) (199)
- Important Role of Rho-kinase in the Pathogenesis of Cardiovascular Inflammation and Remodeling Induced by Long-Term Blockade of Nitric Oxide Synthesis in Rats (2002) (196)
- Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. (2009) (192)
- Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days (2001) (187)
- Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys (2002) (181)
- Rho-Kinase Mediates Angiotensin II-Induced Monocyte Chemoattractant Protein-1 Expression in Rat Vascular Smooth Muscle Cells (2001) (179)
- Essential Role of Vascular Endothelial Growth Factor in Angiotensin II–Induced Vascular Inflammation and Remodeling (2004) (177)
- Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. (2004) (175)
- Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. (2000) (172)
- Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. (1997) (171)
- Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo (2000) (170)
- Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1 (2003) (170)
- Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation (2009) (165)
- Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice (2004) (157)
- Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. (1996) (155)
- Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. (1998) (145)
- Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1α in Induction of Experimental Autoimmune Myocarditis and Effective Anti–Monocyte Chemoattractant Protein-1 Gene Therapy (2005) (144)
- Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo (2006) (143)
- Antiinflammatory and Antiarteriosclerotic Actions of HMG-CoA Reductase Inhibitors in a Rat Model of Chronic Inhibition of Nitric Oxide Synthesis (2001) (141)
- Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic Rabbits (2002) (141)
- Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis (2002) (139)
- Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone (2002) (138)
- Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. (1997) (132)
- Increase in circulating levels of monocyte chemoattractant protein-1 with aging. (1999) (127)
- Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure: Roles of Oxidative Stress and Inflammation (2002) (126)
- Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. (1988) (125)
- Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. (1998) (125)
- Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. (2004) (124)
- Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. (2009) (124)
- Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. (2002) (120)
- Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. (1998) (119)
- Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice1 (2005) (118)
- Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement (2014) (117)
- Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. (1999) (115)
- Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. (2011) (115)
- Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension. (2001) (114)
- Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis (2000) (114)
- Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. (2002) (113)
- Nanoparticle-Mediated Delivery of Nuclear Factor &kgr;B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension (2009) (110)
- Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. (2003) (109)
- Monocyte Chemoattractant Protein-1 Is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice (2004) (109)
- High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism (2010) (106)
- Drp 1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure-Overload-Induced Mitochondrial Dysfunction and Heart Failure (2016) (105)
- Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. (2006) (104)
- Downregulation of Angiotensin II Type 1 Receptor by Hydrophobic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Vascular Smooth Muscle Cells (2001) (103)
- Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes (2014) (103)
- Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration (2012) (103)
- Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. (1994) (99)
- Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells (2004) (99)
- Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. (1996) (98)
- Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure (2009) (95)
- Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: roles of serum cholesterol and spontaneous or induced intimal thickening. (1986) (95)
- Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. (2003) (95)
- Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. (1992) (94)
- Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. (1997) (93)
- Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. (1998) (93)
- Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). (2001) (91)
- Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis (2000) (90)
- Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon-γ Function Blocking in ApoE-Knockout Mice (2007) (90)
- Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. (2002) (89)
- MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner. (2009) (89)
- Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. (1997) (88)
- Molecular Mechanism and Role of Endothelial Monocyte Chemoattractant Protein-1 Induction by Vascular Endothelial Growth Factor (2003) (87)
- Role of Myocyte Nitric Oxide in β-Adrenergic Hyporesponsiveness in Heart Failure (1997) (86)
- Attenuation of Endothelium‐Related Relaxation and Enhanced Responsiveness of Vascular Smooth Muscle to Histamine in Spastic Coronary Arterial Segments From Miniature Pigs (1987) (85)
- A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model (2015) (83)
- Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. (2008) (83)
- Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys (2002) (83)
- Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. (1995) (83)
- Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II (2000) (83)
- Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury (2004) (81)
- Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone (2003) (80)
- Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation (2016) (80)
- Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. (2000) (80)
- Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. (1997) (79)
- Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland. (1998) (79)
- Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension (2011) (78)
- Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. (1999) (77)
- Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys (2007) (75)
- Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease. (2017) (75)
- Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening (2016) (74)
- Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. (2000) (73)
- Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE −/− Mice (2016) (73)
- The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation (2004) (72)
- Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. (1995) (71)
- Important role of endothelium-derived hyperpolarizing factor in shear stress--induced endothelium-dependent relaxations in the rat mesenteric artery. (1999) (69)
- Anti—Monocyte Chemoattractant Protein-1 Gene Therapy Protects against Focal Brain Ischemia in Hypertensive Rats (2004) (69)
- Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model. (2000) (68)
- Effects of cocaine on excitation-contraction coupling of aortic smooth muscle from the ferret. (1991) (68)
- Different Vasculoprotective Roles of NO Synthase Isoforms in Vascular Lesion Formation in Mice (2000) (68)
- Glibenclamide, a putative ATP-sensitive K+ channel blocker, inhibits coronary autoregulation in anesthetized dogs. (1993) (67)
- ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. (1994) (64)
- Apoptosis Induced by Inhibition of Cyclic AMP Response Element–Binding Protein in Vascular Smooth Muscle Cells (2003) (64)
- Nanoparticle-mediated drug delivery system for cardiovascular disease. (2014) (63)
- Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. (2004) (62)
- Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor (2004) (62)
- Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. (2004) (62)
- Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats (2005) (62)
- Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models (2018) (61)
- Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure. (2001) (60)
- Role of Transforming Growth Factor-β1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis (2000) (59)
- Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. (2000) (58)
- Nonendothelial Mesenchymal Cell–Derived MCP-1 Is Required for FGF-2–Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway (2006) (58)
- Thrombin Induces Interleukin-6 Expression Through the cAMP Response Element in Vascular Smooth Muscle Cells (2001) (57)
- Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model. (2013) (56)
- Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. (1996) (55)
- Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. (2001) (54)
- Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries. (2011) (53)
- Therapeutic Neovascularization by Nanotechnology-Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium (2009) (52)
- Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys (2004) (51)
- Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs. (1994) (51)
- Anti-inflammatory Nanomedicine for Cardiovascular Disease (2017) (50)
- Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. (1999) (50)
- Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells (2006) (50)
- Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. (2004) (49)
- Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats (2008) (49)
- Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. (1994) (48)
- Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response. (2013) (48)
- Nanoparticle‐Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia‐Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction (2016) (48)
- Stress Augments Insulin Resistance and Prothrombotic State (2012) (48)
- Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. (2007) (48)
- Mouse models of plaque rupture (2013) (47)
- Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? (2002) (47)
- Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina. (1993) (47)
- Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. (2011) (47)
- Long‐term follow up of initial clinical cases with NF‐κB decoy oligodeoxynucleotide transfection at the site of coronary stenting (2008) (46)
- Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo (1996) (45)
- Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report. (2014) (45)
- Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. (1997) (44)
- Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice. (2019) (44)
- Stent-Based Local Delivery of Nuclear Factor-&kgr;B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits (2006) (43)
- Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently. (2010) (43)
- Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe. (2012) (42)
- NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. (2015) (42)
- Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation. (2017) (42)
- HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. (2003) (42)
- Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo. (1995) (42)
- cAMP-Response Element-Binding Protein Mediates Tumor Necrosis Factor-&agr;–Induced Vascular Smooth Muscle Cell Migration (2004) (42)
- The effect of local IL-4 delivery or CCL2 blockade on implant fixation and bone structural properties in a mouse model of wear particle induced osteolysis. (2016) (41)
- Pathogenesis of coronary artery spasm in miniature swine with regional intimal thickening after balloon denudation. (1987) (41)
- Leukotriene C4- and D4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram: angiographic analysis. (1987) (40)
- Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization in a Murine Model of Hindlimb Ischemia (2012) (40)
- Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. (2017) (40)
- Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1β in Pigs in Vivo (1997) (39)
- Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits (2004) (39)
- Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. (2007) (39)
- Altered serotonin receptor subtypes mediate coronary microvascular hyperreactivity in pigs with chronic inhibition of nitric oxide synthesis. (1996) (38)
- Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions. (2000) (38)
- Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. (2001) (38)
- Local Delivery of Imatinib Mesylate (STI571)–Incorporated Nanoparticle Ex Vivo Suppresses Vein Graft Neointima Formation (2008) (37)
- Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia. (2010) (36)
- Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice (2009) (35)
- Local delivery of mutant CCL2 protein‐reduced orthopaedic implant wear particle‐induced osteolysis and inflammation in vivo (2016) (34)
- Serotonin‐Induced Coronary Spasm in a Swine Model A Minor Role of Defective Endothelium‐Derived Relaxing Factor (1993) (34)
- A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model (2016) (34)
- Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases (2003) (34)
- Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. (2003) (33)
- Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial (2017) (33)
- Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis (2006) (33)
- PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats. (1996) (32)
- Differentiation Between Aberrant Ventricular Conduction and Ventricular Ectopy in Atrial Fibrillation Using RR Interval Scattergram (1993) (32)
- Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension. (2015) (32)
- Beneficial Effects of Atrial Natriuretic Peptide on Exercise‐Induced Myocardial Ischemia in Patients With Stable Effort Angina Pectoris (1993) (31)
- Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft Vasculopathy (2004) (31)
- Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs. (1995) (31)
- Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs. (1999) (31)
- Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice. (2008) (31)
- Postischemic Gene Transfer of Soluble Flt-1 Protects against Brain Ischemia with Marked Attenuation of Blood—Brain Barrier Permeability (2007) (31)
- Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. (1998) (30)
- Pulmonary capillary hemangiomatosis with severe pulmonary hypertension. (2003) (30)
- Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. (2003) (29)
- Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice (2006) (29)
- Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice (2017) (29)
- Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases. (2016) (29)
- The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer. (2005) (28)
- Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. (1990) (28)
- Mechanism of ergonovine-induced hyperconstriction of the large epicardial coronary artery in conscious dogs a month after arterial injury. (1992) (28)
- Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease. (2002) (28)
- Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery. (2002) (27)
- Inhibition of Intrinsic Interferon-&ggr; Function Prevents Neointima Formation After Balloon Injury (2007) (27)
- Enhanced responsiveness of smooth muscle, impaired endothelium-dependent relaxation and the genesis of coronary spasm. (1989) (27)
- Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys. (2007) (26)
- Anti-inflammatory gene therapy for cardiovascular disease. (2011) (26)
- Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding. In vivo and in vitro analysis. (1991) (26)
- Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigs. (1996) (26)
- Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure. (1997) (26)
- Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis (2004) (26)
- NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model. (2015) (25)
- Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice. (2005) (25)
- Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles. (2014) (25)
- Detection of angina-provoking coronary stenosis by resting iodine 123 metaiodobenzylguanidine scintigraphy in patients with unstable angina pectoris. (1995) (25)
- Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. (2000) (25)
- Soluble TNF receptors prevent apoptosis in infiltrating cells and promote ventricular rupture and remodeling after myocardial infarction. (2007) (24)
- Endogenous NO Blockade Enhances Tissue Factor Expression via Increased Ca2+ Influx Through MCP-1 in Endothelial Cells by Monocyte Adhesion (2005) (24)
- Chitinase inhibition promotes atherosclerosis in hyperlipidemic mice. (2013) (24)
- Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II–Induced Atherosclerosis (2008) (24)
- Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. (2001) (23)
- Postnatal Blocking of Interferon-γ Function Prevented Atherosclerotic Plaque Formation in Apolipoprotein E–Knockout Mice (2007) (23)
- Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension (2016) (22)
- Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure. (2001) (22)
- Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates (2004) (22)
- Effects of L-arginine analogues on vasomotion of isolated porcine coronary arteries. (1995) (21)
- Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats. (2001) (20)
- Role of SR Ca2+-ATPase in contractile dysfunction of myocytes in tachycardia-induced heart failure. (1998) (20)
- The role of endothelium‐derived nitric oxide in acetylcholine‐induced coronary vasoconstriction in closed‐chest pigs (1993) (20)
- Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigs. (1996) (19)
- Endocardial versus epicardial differences of sarcoplasmic reticulum Ca2+-ATPase gene expression in the canine failing myocardium (1999) (18)
- Critical role of the C5a-activated neutrophils in high-fat diet-induced vascular inflammation (2016) (18)
- Neutrophil‐dominant experimental autoimmune uveitis in CC‐chemokine receptor 2 knockout mice (2011) (18)
- Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice (2020) (18)
- Preservation of Endothelial Function by the HMG-CoA Reductase Inhibitor Fluvastatin through Its Lipid-Lowering Independent Antioxidant Properties in Atherosclerotic Rabbits (2003) (17)
- Disparity of MCP-1 mRNA and Protein Expressions Between the Carotid Artery and the Aorta in WHHL Rabbits: One Aspect Involved in the Regional Difference in Atherosclerosis (2003) (17)
- Positive Inotropic Effects of Calcium Sensitizers on Normal and Failing Cardiac Myocytes (2001) (17)
- The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 beta in porcine coronary arteries in vivo. (1996) (17)
- Endothelial dysfunction and coronary atherosclerosis. (2004) (16)
- A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates (2006) (16)
- Safety, Tolerability, and Pharmacokinetics of NK-104-NP. (2018) (16)
- Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols (2018) (16)
- Long-term prognosis of vasospastic angina without significant atherosclerotic coronary artery disease. (1987) (15)
- Increased expression of L-type calcium channels in vascular smooth muscle cells at spastic site in a porcine model of coronary artery spasm. (2000) (15)
- Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries. (1991) (15)
- Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo. (1997) (15)
- Macrophage (Drp1) Dynamin-Related Protein 1 Accelerates Intimal Thickening After Vascular Injury (2020) (15)
- Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure. (2000) (15)
- Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts. (2000) (15)
- Platelet activating factor causes hyperconstriction at the inflammatory coronary lesions in pigs in vivo (1997) (14)
- BubR 1 Insuf fi ciency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein EDe fi cient Mice (2016) (14)
- Transfection With a Dominant-Negative Inhibitor of Monocyte Chemoattractant Protein-1 Gene Improves Cardiac Function After 6 Hours of Cold Preservation (2003) (14)
- Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells. (2007) (13)
- Coronary artery spasm during hydrocortisone-induced allergic reactions. (1987) (13)
- Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo. (1996) (13)
- Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy. (2000) (13)
- Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats. (2018) (13)
- Role of Ca2+ availability to myofilaments and their sensitivity to Ca2+ in myocyte contractile dysfunction in heart failure. (1999) (12)
- Silent myocardial ischemia in patients with variant angina. (1989) (12)
- Nanoparticle‐Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia‐Reperfusion Injury (2021) (12)
- Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells (2020) (12)
- Heterogeneous effects of the endothelium‐dependent vasodilators acetylcholine and substance P on the coronary circulation of patients with angiographically normal coronary arteries (1992) (12)
- Severe pulmonary hypertension in a patient with systemic lupus erythematosus and minimal lupus activity. (2002) (11)
- Coronary vascular ATP-sensitive potassium channels are activated to a greater extent in spontaneously hypertensive rats than in Wistar-Kyoto rats. (1996) (11)
- Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1beta in pigs in vivo. (1997) (10)
- Endothelium‐Derived Nitric Oxide Does Not Modulate Metabolic Coronary Vasodilation Induced by Tachycardia in Dogs (1995) (10)
- Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists. (1997) (10)
- Role of SR Ca2+-ATPase in contractile dysfunction of myocytes in tachycardia-induced heart failure. (1998) (10)
- Multiple coronary-to-pulmonary artery fistulas with progressive aneurysmal dilatation. (1984) (10)
- Nitric oxide activity at the site of coronary spasm: deficient or preserved? (1997) (9)
- Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe −/− Mice (2021) (8)
- ATP-sensitive K+ channel opener pinacidil augments beta 1-adrenoceptor-induced coronary vasodilation in dogs. (1996) (8)
- Correlations between recruitable coronary collateral flow velocities, distal occlusion pressure, and electrocardiographic changes in patients undergoing angioplasty. (1997) (8)
- BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice (2016) (8)
- Inhibition of adhesion molecules markedly ameliorates cytokine-induced sustained myocardial dysfunction in dogs in vivo. (1998) (8)
- Abnormalities of cardiac sympathetic neuronal and left ventricular function in chronic mitral regurgitation: assessment by iodine-123 metaiodobenzylguanidine scintigraphy. (1996) (7)
- Central role of vascular smooth muscle hyperreactivity in coronary hyperconstriction after balloon injury in miniature pigs (1997) (6)
- Augmented vasodilator response to l-arginine after coronary angioplasty may attenuate restenosis (2002) (6)
- Response by Shirakabe et al to Letter Regarding Article, "Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure". (2016) (6)
- Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury (2020) (6)
- [Angiotensin II receptor and oxidative stress]. (2002) (6)
- Effects of N-nitro‐L-arginine on coronary artery tone and reactive hyperemia after brief coronary occlusion in conscious dogs (1994) (6)
- [Molecular mechanism of in-stent restenosis and novel treatment strategy of gene-eluting stent developed with bioabsorbable nanoparticle electrodeposition]. (2007) (5)
- Cardiac angiotensin II receptors are downregulated by chronic angiotensin II infusion in rats. (2000) (5)
- Effects of intracoronary infusion of atrial natriuretic peptide on pacing‐induced myocardial ischemia in patients with effort angina pectoris (1994) (5)
- Role of SR Ca 2 -ATPase in contractile dysfunction of myocytes in tachycardia-induced heart failure (1998) (5)
- Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure. (2001) (5)
- Beneficial Effect of Cholesterol‐Lowering Therapy on Endothelium‐Dependent Coronary Vasodilation in Patients with Hypercholesterolemia a (1994) (4)
- Hideharu Tomita , Hiroaki Oxide Synthesis in Rats Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric (1998) (4)
- Vasospastic angina in patients with systemic triglyceride storage disease with Jordans' anomaly and cardiomyopathy. (1996) (4)
- , Shujiro a Rat Model of Chronic Inhibition of Nitric Oxide Synthesis Antiinflammatory and Antiarteriosclerotic Actions of HMG-CoA Reductase Inhibitors in (2001) (3)
- Activation of protein kinase C induces coronary vasospasm at the interleukin-1-beta-induced inflammatory/proliferative lesion in a swine model in vivo (1994) (3)
- Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs. (1992) (3)
- [NO and atherosclerosis]. (2004) (3)
- Prostanoids, coronary circulation and coronary artery spasm in open chest dogs and miniature pigs. (1987) (3)
- [Vascular remodeling and nitric oxide]. (1997) (3)
- BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice (2017) (3)
- Intravenous cocaine causes constriction of coronary arteries in the intact miniature pig (1990) (3)
- Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primates (2016) (3)
- Stress Augments Insulin Resistance and Prothrombotic State Role of Visceral Adipose-Derived Monocyte Chemoattractant Protein-1 (2012) (3)
- EFFECTS OF ATHEROGENIC DIETS ON SERUM CONTENT OF CHOLESTEROL, HISTAMINE-INDUCED CORONARY CONSTRICTION AND MORPHOLOGICAL CHANGES OF THE CORONARY ARTERY : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (3)
- Abstract 4397: Pitavastatin Incorporated Nanoparticle-eluting Stents Attenuate In-stent Stenosis Without Anti-healing Effects Induced by Sirolimus-eluting Stents (cypher) in Porcine Coronary Artery Model (2009) (2)
- -449- THE MECHANISM OF ERGONOVINE-INDUCED HYPERCONTRACTION IN THE LARGE EPICARDIAL CORONARY ARTERY ONE MONTH AFTER ENDOTHELIAL DENUDATION IN CONSCIOUS DOGS (1987) (2)
- [Statins in the management of acute coronary syndrome]. (2010) (2)
- Abstract 17380: Nanoparticles-Mediated Delivery of Pioglitazone Reduces Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-mediated Inflammation in Mice and Mini Pigs (2014) (2)
- Acute myocardial infarction following asymptomatic ST elevation despite diltiazem therapy. (1985) (2)
- Effects of iomeprol, a new nonionic contrast medium, vis a vis iopamidol and nitroglycerin, on coronary diameter and blood flow in chronically instrumented dogs (1993) (2)
- Nanoparticle-Mediated Endothelial Cell-Selective Drug Delivery System (2017) (2)
- arterial thrombogenecity in rat carotid artery Long-term inhibition of nitric oxide synthesis increases (2005) (2)
- Fibrosis in Mice Gene Therapy Attenuates Lung Injury and Anti-Vascular Endothelial Growth Factor (2005) (2)
- Role of Transforming Growth Factor-b1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis (2000) (2)
- Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial (2021) (2)
- Role of Transforming Growth Factor-b 1 in Cardiovascular Inflammatory Changes Induced by Chronic Inhibition of Nitric Oxide Synthesis (2000) (2)
- Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia (2020) (2)
- Post-&bgr;-Receptor Impairment in the Regulation of Myofibrillar Ca 2+ Sensitivity in Tachypacing-Induced Canine Failing Heart (2002) (2)
- [Vascular remodeling and angiotensin II]. (1999) (2)
- S28-2 IMPACT OF NANOTECHNOLOGY-BASED DRUG DELIVERY SYSTEM (NANODDS) FOR TREATMENT OF CARDIOVASCULALR DISEASE (2007) (2)
- cAMP-Response Element-Binding Protein Mediates Prostaglandin F_2α-Induced Hypertrophy of Vascular Smooth Muscle Cells (2003) (1)
- A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects (2018) (1)
- Murine Model of Hindlimb Ischemia Nanoparticle-Mediated Delivery of Pioglitazone Enhances Therapeutic Neovascularization (2012) (1)
- Mechanism of coronary artery spasm in atherosclerotic miniature swine (1986) (1)
- Abstract 434: A New Drug Delivery System Using Fibronectin-vegf Fusion Is More Effective And Harmless Than Vegf Alone For The Therapeutic Neovascularization (2007) (1)
- Endothelin-1 is not involved in serotonin-induced coronary spasm in a swine model. (1995) (1)
- Feasibility of in vitro studies of coronary spasm (1986) (1)
- PE-318 Vascular Endothelial Growth Factor is an Essential Mediator in the Development of Angiotensin II-induced Arteriosclerosis(Atherosclerosis, Basic 4 (IHD) : PE54)(Poster Session (English)) (2004) (1)
- The effects of gene transer of soluble TFG-β type II receptor and soluble VEGF type I receptor (Flt-1) in peritoneal fibrosis model of mice; balance between inflammation and fibrosis (2003) (1)
- Beneficial Effects of Atrial Natriuretic Peptide (2005) (1)
- Chemoattractant Protein-1 Expression in Rat Hearts and Vessels Inhibition of NO Synthesis Induces Inflammatory Changes and Monocyte (1998) (1)
- The effects of cocaine on the coronary vascular bed of isoflurane-anesthetized miniature swine (1991) (1)
- [Anti-inflammatory effect of HMG-CoA reductase inhibitors]. (2004) (1)
- Cardiomyopathy secondary to systemic triglyceride storage disease (1997) (1)
- Immediate relief of spontaneous coronary artery spasm by intracoronary infusion of an endothelium-dependent vasodilator, substance P. (1995) (1)
- Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in non-human primates (2006) (1)
- Abstract 1320: A Novel Nanotechnology-Based Strategy for Therapeutic Neovascularization: Local Delivery of Statin with Biodegradable Polymeric Nanoparticle Improves Therapeutic Efficacy of Ischemic Neovascularization (2006) (1)
- Endothelial Dysfunction in Cardiac Syndrome X (Microvascular Angina) (1999) (1)
- CORONARY ARTERY DISEASE Leukotriene C 4-and D 4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram : angiographic analysis (2005) (1)
- Pathogenesis of Coronary Artery Spasm (1987) (1)
- 172 Marked reduction in infarct size and recovery of ventricular function following experimental coronary thrombolysis by single chain tissue plasminogen activator in dogs (1988) (1)
- HMG-CoA Reductase Inhibitor Limits Angiotensin II-Induced Progression and Destabilization of Established Atherosclerosis in ApoE-Knockout Mice through Its Cholesterol-Lowering Independent Actions (2003) (1)
- Anti-monocyte chemoattractant protein-1 gene therapy inhibits neointimal hyperplasia after balloon angioplasty in rats and monkeys (2002) (1)
- Prompt relief of vasospastic angina by calcium antagonists. (1987) (1)
- Abstract: 65 CHOLESTEROL-LOWERING THERAPY WITH THE CHOLESTEROL ABSORPTION INHIBITOR EZETIMIBE INHIBITS PLAQUE DESTABILIZATION AND RUPTURE IN THE BRACHIOCEPHALIC ARTERIES OF APOE-DEFICIENT MICE (2009) (0)
- PE-037 An Essential Role of Angiotensin II Type 1 Receptor in Arterial Wall, Not in Bone Marrow, in Angiotensin II-Induced Atherosclerosis(Atherosclerosis, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- Abstract 15677: Nanoparticle-Mediated Targeting of Pitavastatin Into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Pig Model (2013) (0)
- Brief Definitive Communication Glibenclamide, a Putative ATP-Sensitive K' Channel Blocker, Inhibits Coronary Autoregulation inAnesthetized Dogs (1993) (0)
- Local Gene Transfer via Gene-Eluting Stents for Prevention of Restenosis : An Anti-inflammation Strategy for Next-Generation Intravascular Therapy(New Technologies in the Drug-Eluting Stent Era, The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
- Lipid-lowering therapy with Ezetimibe Inhibits Spontaneous Atherothrombosis in a Rabbit Model of Plaque Erosion - A Role of Serum Oxysterols (2018) (0)
- coronary artery in conscious dogs a month after arterial injury Mechanism of ergonovine-induced hyperconstriction of the large epicardial (2011) (0)
- Nanoparticle-mediated drug delivery system for coronary artery disease (2015) (0)
- C5a play an important role in high fat diet-induced neutrophil activation (2016) (0)
- PJ-375 Nanoparticle-Mediated Intracellular Delivery of Imatinib, a PDGF-Receptor Tyrosine Kinase Inhibitor, in Porcine Coronary Arteries from Nanoparticle-Eluting Stent Attenuates Neointimal Formation(Restenosis basic/clinical(04)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of t (2008) (0)
- IS010 3-Hydroxyl-3-Methylgutaryl(HMG)-CoA Reductase Inhibitors Attenuate Inflammatory and Proliferative Changes of Rat Hearts and Vessels Induced by Chronic Inhibition of NO Synthesis (1999) (0)
- Abstract 18536: Nanoparticle-mediated Simultaneous Targeting to Mitochondria and Inflammatory Monocytes Confers Additive Cardioprotection Against Myocardial Ischemia-reperfusion Injury (2015) (0)
- -264-EFFECTS OF LEUKOTRIENE C_4, D_4, AND FPL-55712 ON PROVOCATION AND PREVENTION OF CORONARY ARTERY SPASM IN MINIATURE PIGS (1986) (0)
- Systemic Delivery of Bone Marrow Mononuclear Cells(BM-MNC) Accelerates Reendothelialization and Markedly Attenuates Intimal Hyperplasia in Balloon-Injured Carotid Artery (2002) (0)
- Abstract P268: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Myocardial Ischemia/Reperfusion Injury (2011) (0)
- Abstract 13315: Nanoparticle-Mediated Monocyte-Selective Delivery of Pitavastatin Prevents Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in ApoE-Deficient Mice (2010) (0)
- 腎虚血再灌流傷害の治療・改善・予防剤 (2003) (0)
- Abstract 16268: A Novel Multi-Targeting Approach for Myocardial Ischemia-Reperfusion Injury: Nanoparticle-Mediated Delivery of Irbesartan Reduces Ischemia/Reperfusion Injury in Mice (2012) (0)
- Anti-Monocyte Chemoattractant Protein-1 Therapy Reduces Experimental In-Stent Restenosis in Hypercholesterolemic Rabbits (2003) (0)
- Nanoparticle-mediated delivery of angiotensin II receptor antagonist, olmesartan medoxomil into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension in rats (2009) (0)
- Th-W57:4 Stent-based delivery of nuclear factor-KB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits (2006) (0)
- The Role of VEGF System in Restenosis and Arteriosclerosis (2003) (0)
- 物品、物品の製造方法、物品の貼り付け方法 (2015) (0)
- Blockade of Vascular Endothelial Growth Factor Signals by sFLT-1 Gene Transer Attenuates Neointimal Hyperplasia after Perivascular Injury in Mice (2002) (0)
- thickening after balloon denudation Pathogenesis of coronary artery spasm in miniature swine with regional intimal (2011) (0)
- Abstract 13860: An Unique Animal Model of Spontaneous Atherothrombotic Occlusion due to Plaque Erosion at Femoral Arteries of Atherosclerotic Rabbits Infused with Angiotensin II (2012) (0)
- Analysis of Flow Dynamics of Internal Thoracic Arterial Bypass Graft Using a Doppler-tipped Guidewire (1994) (0)
- 282 EZETIMIBE IMPROVES NAFLD AGGRAVATION INDUCED BY DIETARY CHOLESTEROL OXIDATION PRODUCTS IN NON-HUMAN PRIMATES (2011) (0)
- Abstract 8984: A New Therapeutic Modality for Ischemia-Reperfusion Injury: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Myocardial Ischemia/Reperfusion Injury in Rats (2011) (0)
- Clinical application for intra-coronary nanodds devices (2012) (0)
- Abstract 5536: Mechanisms Underlying Coronary Vasopsasm at Distal Arterial Segments of Sirolimus-Eluting Stent Implantation in a Porcine Model (2008) (0)
- [AII and inflammation]. (2006) (0)
- Blockade of Nitric Oxide Synthesis Increases Vascular Superoxide Anion Production from the Endothelial Cells (1997) (0)
- Intracellular oxygen free radicals are important in the pathogenesis of coronary endothelial dysfunction in a canine model of tachycardiainduced heart failure (1998) (0)
- Future directions in the treatment of coronary artery disease (2016) (0)
- Agent for treating lung diseases (2008) (0)
- [Therapeutic neovascularization by nanotechnology-mediated drug delivery system]. (2009) (0)
- Peroxisome proliferator-activated receptor y activator attenuates left ventricular remodeling and failure after experimental myocardial infarction (2002) (0)
- PJ-336 Pitavastatin Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis, and Prevents Adverse Effects of Silorimus-Eluting Cypher Stent in Porcine Coronary Artery Model(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japa (2009) (0)
- -P115- THE ROLE OF ENDOTHELIUM AND SMOOTH MUSCLE ON CORONARY ARTERY SPASM IN MINIATURE PIGS (1987) (0)
- OJ-212 Nanoparticle-Mediated Intracellular Delivery of Pitavastatin to Endothelial Progenitor Cells Ex Vivo Recovers the Functional Activity for Therapeutic Neovascularization(OJ36,Peripheral Circulation/Vascular Disease (Therapy) 2 (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting (2009) (0)
- BIOLOGICAL STRATEGIES FOR TREATMENT OF WEAR PARTICLE-INDUCED PERIPROSTHETIC OSTEOLYSIS (2014) (0)
- OJ-081 Sustained Intracellular Delivery of Nanoparticles in Porcine Coronary Arteries from a Bioabsorbable Polymeric Nanoparticle-Eluting Stent(Coronary revascularization, PCI-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- IS015 Enhanced myocardial generation of oxygen radicals in heart failure (1998) (0)
- Abstract: P182 PITAVASTATIN INCORPORATED NANOPARTICLE-ELUTING STENT ATTENUATES IN-STENT STENOSIS, AND PREVENTS ADVERSE EFFECTS OF SILORIMUS-ELUTING CYPHER STENT IN PORCINE CORONARY ARTERY MODEL (2009) (0)
- P3785Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice (2018) (0)
- Abstract 15120: Nanoparticle-Mediated Delivery of Pitavastatin into Small Pulmonary Arteies by Intravenous Administration Attenuated the Progression of Already Established Monocrotaline-induced Pulmonary Arterial Hypertension in Rats (2014) (0)
- The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 / 3 in porcine coronary arteries in vivo 1 (2006) (0)
- Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently (2012) (0)
- Defects of intracellular calucium availability to the myofilaments are responsible for myocardial contractile dysfunction in heart failure (1998) (0)
- 2 Stent-Based Local Delivery of Nuclear Factor-k B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits(Young Investigator's Award Finalists Lecture (YIA),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
- , Oxide Synthesis by Recruiting / Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis (2002) (0)
- Abstract 14531: Chitinase Inhibitor, Allosamidin, Accelerates Atherosclerotic Lesions in Hyperlipidemic Mice by Influencing M1/M2 Polarization and Cholesterol Metabolism in Macrophages (2012) (0)
- Abstract 5860: Nanoparticle-Mediated Endothelial Cell-Selective Delivery of Statin Increases Functional Collateral Vessel Development (Arteriogenesis) and Prevents Exercise-Induced Ischemia in Rabbit Hindlimb Ischemia (2008) (0)
- Tyrosine Kinase Inhibitor Suppresses Coronary Arteriosclerotic Changes and Vasospastic Responses Induced by Chronic Treatment with Interleukin-lf in Pigs In Vivo changes and vasospastic responses to autacoids (0)
- Abstract 17056: Nanoparticles-mediated Targeting of Pioglitazone Reduces Myocardial Ischemia-reperfusion Injury and Cardiac Remodeling by Antagonizing Monocyte-mediated Inflammation in Preclinical Animal Models (2015) (0)
- Polyurethane resin excellent in elongation physical property at high temperature (1991) (0)
- Functional Significance and Flow Characteristics of Recruitable Coronary Collaterals in Human. A Prospective Study During Angioplasty Using a Doppler-tipped Guidewire (1994) (0)
- Abstract 15889: Nanoparticle-Mediated Selective Delivery into Lesions of Myocardial Ischemia-Reperfusion Injury Enhances Cardioprotection by Cyclosporine A in Mice (2012) (0)
- OE-123 Blockade or Abrogation of Angiotensin II AT1 Receptor Suppressed Accelerated Diabetic Atherosclerosis in Streptozotosin-Induced Diabetic Apolipoprotein E-Deficient Mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English)) (2004) (0)
- Abstract 3042: Two-Year Follow Up of Initial Clinical Cases With an NF-kB Decoy Transfection at the Site of the Coronary Stenting (2006) (0)
- Upregulation of Monocyte Chemoattractant Protein (MCP)-1 Receptor in Circulating Monocytes Contributes to Angiotensin II : Induced Arteriosclerosis/Atherosclerosis (2003) (0)
- PE-334 Parallel Increases in LV End-systolic Elastance and Arterial Elastance in Elderly Japanese with Hypertension Make Apparent Systolic Function Normal(Echo/Doppler-12, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- Abstract 1176: Vascular Endothelial Growth Factor Accelerates Neointima Formation Through Flk-1 After Wire Injury In Flt-1 Tyrosine Kinase-deficient Mice (2007) (0)
- Effects of nicorandil on coronary circulation and coronary flow reserve in patients with chronic effort angina (1991) (0)
- Abstract 3964: Nanoparticle-Mediated Monocyte-Selective Transfection of Dominant-Negative Monocyte Chemoattractant Protein-1 (MCP-1) Gene Inhibits Plaque Rupture in ApoE-Deficient Mice (2008) (0)
- Identification of a novel gene involved in the pathogenesis of cardiac hypertrophy in rats (2002) (0)
- OE-120 Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin in nonhuman primates(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English)) (2004) (0)
- P2-27 AN INNOVATIVE THERAPEUTIC APPROACH FOR PULMONARY ARTERIAL HYPERTENSION: SINGLE INTRATRACHEAL ADMINISTRATION OF BIOABSORBABLE NANOPARTICLE INCORPORATED WITH STATIN AMELIORATES MONOCROTALINE-INDUCED PULMONARY ARTERY HYPERTENSION AND SURVIVAL (2007) (0)
- Kensuke Egashira to Monocyte Chemoattractant Protein-1 Molecular Mechanisms Mediating Inflammation in Vascular Disease : Special Reference (2003) (0)
- Pathogenesis of Coronary Artery Spasm Role of Intimal Thickening, Hypercholesterolemia, and Endothelial Denudation on Coronary Hypercontraction to Histamine in Miniature Swine (1987) (0)
- Tu-P8:294 Essential role of increased release of MCP-1 in the mechanism of platelet-derived growth factor (PDGF)-induced proliferation and migration of vascular smooth muscle cells (2006) (0)
- , Masamichi Koyanagi , in Rats Contributes to Cardiac Fibrosis Induced by Long-term Blockade of Nitric Oxide Synthesis via Angiotensin II Type 1 Receptors β Early Induction of Transforming Growth (1998) (0)
- 3 Anti-Monocyte Chemoattractant Protein-1 (MCP-1) Therapy Against Restenosis(Plenary Session 4 (PL4) (IHD) : Restenosis after PCI 2003 : New Therapies for the Next Generation)(Special Program) (2004) (0)
- Blockade of Vascular Endothelial Growth Factor Attenuates Experimental Restenosis after Intraluminal Injury (2003) (0)
- [Vascular endothelial function in coronary artery spasm]. (1992) (0)
- Anti-monocyte chemoattractant protein-1 gene therapy protects against experimental autoimmune myocarditis (2002) (0)
- A innovative anti-inflammatory therapeutic strategy for regeneration of atherosclerosis with biodegradable gene eluting stent (2006) (0)
- 1P-0193 Vascular endothelial growth factoris essential in experimetnal restenosis after intraluminal injury (2003) (0)
- The role of endothelial function in the pathogenesis of coronary spasm in humans : Physiol1ogical and pathophysiological roles of vascular endothelium-derived vasoactive substance (1993) (0)
- Endothelium-dependent dilatation in patients with augine pectorics and normal coronary angiograms (1994) (0)
- Abstract 400: Statin and Ezetimibe Differently Affect Spontaneous Atherothrombotic Occlusion in a Rabbit Model of Plaque Erosion (2017) (0)
- Nanoparticles-Mediated Targeting of Pioglitazone Reduces Myocardial Ischemia-Reperfusion Injury and Cardiac Remodeling by Antagonizing Monocyte/Macrophage-mediated Inflammation in Preclinical Animal Models (2016) (0)
- Abstract 14130: Nanoparticle-mediated Endothelial Cell-selective Delivery of Pioglitazone Enhances Therapeutic Efficacy of Therapeutic Angiogenesis and Arteriogenesis after Hindlimb Ischemia in Mice (2010) (0)
- Abstract 13845: Intramural Delivery of Pitavastatin Using a Novel Composite Drug Delivery System (Nanoparticle and Pulse Wave Infusion Catheter) Attenuates Neointima Formation after Balloon Injury in Porcine Coronary Arteries (2012) (0)
- Pioglitazone prevents Coronary Arteriosclerosis through inhibition of inflammation by downregulation of monocyte CCR2 in Rat (2002) (0)
- Abstract 260: Nanoparticle-mediated Simultaneous Targeting to Mitochondria and Inflammatory Monocytes Confers Additive Cardioprotection Against Myocardial Ischemia-reperfusion Injury (2015) (0)
- Abstract 973: A Novel Anti-Inflammatory Therapeutic Approach for Pulmonary Arterial Hypertension: Blockade of NF-kB by Nano-DDS of NF-kB decoy to the lung ameliorates monocrotaline-induced PAH (2007) (0)
- Abstract 15266: Nanoparticle-Mediated Simultaneous Targeting of Mitochondria and Inflammatory Monocytes Attenuates Cerebral Ischemia-Reperfusion Injury in Mice (2017) (0)
- Abstract 3605: Nanoparticle-based Monocyte-Selective Delivery of PPAR{gamma} Agonist Pioglitazone Inhibits Plaque Rupture in ApoE-Deficient Mice (2008) (0)
- Abstract 12674: Nanoparticles-Mediated Delivery of Irbesartan Reduces Myocardial Ischemia/Reperfusion Injury via PPAR?-Dependent Anti-Inflammatory Mechanisms in Mice (2013) (0)
- The Journal of Gene Medicine Japanese Society of Gene Therapy Young Investigator Award 2003 (2005) (0)
- Enhanced Expression of MCP-1 Receptor in Circulating Monocytes in Hypertensive Patients through Angiotensin II Type 1 Receptor (2003) (0)
- Tyrosine kinase inhibitor suppresses the (re)stenotic changes of the coronary artery after balloon injury in pigs 1 (1997) (0)
- A gene therapy targeting early growth response factor-1 by "decoy" strategy inhibits neointinal hyperplasia in hypercholesterolemic rabbits (2002) (0)
- Abstract 15381: Nanoparticle-mediated Delivery of Pioglitazone Ameliorates Inflammation and Inhibits Atherosclerotic Plaque Rupture in Apolipoprotein-E Deficient Mice (2014) (0)
- A novel bioabsorbable polymeric nanoparticle drug or gene eluting stent developed using electro-deposit nanoparticle-coating technology (2007) (0)
- Abstract 5798: Nanoparticle-mediated Endothelial Cell-selective Delivery of Pioglitazone Improves Therapeutic Efficacy of Ischemic Neovascularization (2009) (0)
- ATP-sensitive K+ channels and metabolic vasodilation in coronary circulation (1994) (0)
- Antioxidant therapy with tiron improves coronary vasodilating capacity to ischemia and adenosine by increasing nitric oxide bioactivity in a tachycardiainduced heart failure (1999) (0)
- Soluble FLt-1 Gene Transfer Attenuates Neointimal Hyperplasia after Perivascular Injury in Apoliporotein-E Knockout Mice (2003) (0)
- Abstract 14142: NPC1L1 Inhibition with Ezetimibe Suppresses Enhanced Formation of Aortic Atherosclerosis Induced by Dietary Cholesterol Oxidation Products in ApoE-deficient Mice (2010) (0)
- Ischemic heart disease. Advances in diagnosis and treatment I. Epidemiology and disease state 3. Vascular endothelial cell failure and ischemic heart disease. (2000) (0)
- Abstract 13004: Intensive Lipid-Lowering Therapy by Pitavastatin Ameliorates Coronary Hypercontraction After Stenting, the CONTRACTION Study (2011) (0)
- 3P-0911 Regression and stabilization of atherosclerosis by a cholesterol-lowering independent anti-inflammation effect of statin in cynomolgus monkeys (2003) (0)
- Dietary oxysterols and atherosclerosis (2011) (0)
- Monocyte chemoattractant protein-1 activates a regional Th 1 immuno-response in nephritis of MRL / lpr mice (2005) (0)
- Monocyte Chemoattractant Protein-1 is Vital in Angiotensin II-induced Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice (2002) (0)
- Remodeling Induced by Long-Term Blockade of Nitric Oxide Synthesis in Rats Important Role of Rho-kinase in the Pathogenesis of Cardiovascular Inflammation and (2002) (0)
- Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon- (cid:1) Function Blocking in ApoE-Knockout Mice Molecular Medicine (2007) (0)
- Pulmonary Hypertension Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension (2017) (0)
- A case of indocyanine green excretion defect worsened during acute hepatitis following sudden deafness. (1985) (0)
- The Involvement of Oxidized Phospholipids in Choroidal Neovascularization (2009) (0)
- Application of nanotechnology to cardiovascular disease (2010) (0)
- Suppression of Neointimal Formation in a Canine Model of Vein Graft Disease by Adenovirus-Mediated Anti Monocyte Chemoattractant Protein-1 Gene Therapy(Gene Therapy 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
- Effects of calcium sensitizer on myocyte contractile function in tachycardia-induced heart failure (1999) (0)
- Nanoparticle-Mediated Targeting of Pitavastatin into Small Pulmonary Arteries by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats (2016) (0)
- Abstract 15162: Nanoparticle-Mediated Simultaneous Targeting to Mitochondria and Inflammatory Monocytes Confers Additive Cardioprotection Against Myocardial Ischemia-Reperfusion Injury (2014) (0)
- 2422Nanoparticle-mediated delivery of toll-like receptor 4 antagonist to monocytes and ischemic myocardium enhances cardioprotection against ischemia-reperfusion injury in mice (2018) (0)
- [The role of nitric oxide in ischemic heart disease]. (2003) (0)
- Stromal Cell-Derived Factor-1α Gene Transfer Induces Therapeutic Angiogenesis by Recruiting Endothelial Progenitor Cells via the VEGF/eNOS Pathway (2003) (0)
- OE-064 Critical Role of Angiotensin II AT1 Signals in Vascular Senescence in Atherogenesis(Atherosclerosis, basic-1 (H) OE11,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
- Abstract 13425: Nanoparticle-Mediated Monocyte-Selective Delivery of Pitavastatin Inhibits Monocyte Activation and Attenuates Plaque Destabilization and Rupture in ApoE-Deficient Mice (2010) (0)
- IS037 3-Hydroxyl-3-Methylglutaryl(HMG)-CoA Reductase Inhibitors Attenuate Cardiovascular Inflammatory Changes and Cardiovascular Remodeling in a Rat Model of Chronic Inhibition of NO Synthesis (2000) (0)
- -329- EFFECTS OF ANTIANGINAL DRUGS ON PREVENTION OF VASOSPASTIC ANGINA IN MINIATURE PIGS (1987) (0)
- [Vascular endothelial dysfunction and ischemic heart disease]. (2000) (0)
- Effects of a new calcium antagonist, CD-832, on experimental coronary artery spasm in miniature pigs (1993) (0)
- Abstract 14184: NPC1L1 Inhibition with Ezetimibe Prevents Accelerated Plaque Destabilization and Rupture Induced by Dietary Cholesterol Oxidation Products in ApoE-deficient Mice (2010) (0)
- Abstract 3443: Nanoparticle-Mediated Intracellular Delivery of Imatinib, a PDGF Receptor Tyrosine Kinase Inhibitor, in Porcine Coronary Arteries from Nanoparticle-Eluting Stent Attenuates Neointimal Formation (2007) (0)
- Trans-Differentiation of Bone Marrow Monocyte-Lineage Cells to Endothelial-Like Cells and Reendothelialization on Injured Endothelium by MCP-1-Dependent Adhesion (2003) (0)
- Abstract 258: Nanoparticle-mediated Targeting of a Chemical Inhibitor of Drp1 to the Mitochondria Induces Cardioprotection From Myocardial Ischemia-reperfusion Injury (2015) (0)
- Myocardial Infarction Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular (2003) (0)
- Abstract 17538: Nanoparticle-Mediated Targeting of a Mitochondria Division Inhibitor, Mdivi-1, to the Mitochondria Induces Cardioprotection from Ischemia-Reperfusion Injury (2014) (0)
- An oxygen free radical scavenger tiron improves coronary endothelial dysfunction in a canine model of tachycardia-induced heart failure (1999) (0)
- Angiotensin II AT1 Receptor-Mediated Enhanced RAGE Signals are Responsible for the Mechanism of Accerelated Atherosclerosis by Diabetes Mellitus(Atherosclerosis, Basic 10 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
- Abstract 2879: Targeted and Tailored: A New Approach to Regeneration after a Myocardial Infarction (2008) (0)
- P698High cholesterol diet and angiotensin II induce spontaneous atherothrombotic occlusion of balloon-injured rabbit femoral arteries; effects of lipid-lowering therapies (2017) (0)
- P1270Nanoparticle-mediated simultaneous targeting of mitochondria and inflammatory monocytes protects the brain from ischemia-reperfusion injury in mice (2018) (0)
- LACS Gene Prmoter Potentially Regulated by Cardiac Specific Transcriptional Factors (2004) (0)
- Cascade of Pathophysiological Events Leading to Spasm of Coronary Arteries (1991) (0)
- Pharmaceutical composition containing a nanoparticle encapsulated statin (2007) (0)
- Nanotechnology-mediated drug targeting for the development of innovative therapeutic strategies in treatment-refractory Cardiovascular diseases (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kensuke Egashira?
Kensuke Egashira is affiliated with the following schools:
